LVORX | Value Opportunities Fund Class R3 | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Value Opportunities Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Value Opportunities Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small and mid-sized U.S. companies.

Fund Basicsas of 05/31/2022

Total Net Assets
$1.47 B
Inception Date
09/28/2007
Dividend Frequency
Annually
Fund Expense Ratio
1.40%
Number of Holdings
68

Fund Expense Ratio :

1.40%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -15.50% -8.27% 12.41% 7.56% 10.39% 7.67%
Lipper Category Avg. Mid-Cap Core Funds -9.25% -3.51% 12.53% 9.11% 11.26% -
Russell 2500™ Index -13.55% -11.62% 12.05% 9.76% 12.00% 8.38%

Fund Expense Ratio :

1.40%

Fund Expense Ratio :

1.40%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -9.80% 2.44% 12.94% 9.01% 10.06% 8.24%
Lipper Category Avg. Mid-Cap Core Funds -4.50% 7.47% 13.46% 10.39% 10.95% -
Russell 2500™ Index -5.82% 0.34% 13.79% 11.57% 12.09% 9.13%

Fund Expense Ratio :

1.40%

TEN LARGEST HOLDINGS as of 05/31/2022View Portfolio

Holding Assets
Chesapeake Energy Corp 2.9%
Devon Energy Corp 2.9%
Valvoline Inc 2.4%
STERIS PLC 2.2%
American Financial Group Inc/OH 2.1%
Entegris Inc 2.1%
Crane Holdings Co 2.0%
Molina Healthcare Inc 2.0%
Booz Allen Hamilton Holding Corp 1.9%
Littelfuse Inc 1.9%

INVESTMENT TEAM

John C. Hardy
John C. Hardy

Portfolio Manager

19 Years of Industry Experience

Supported By 35 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

1.40%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -15.50% -8.27% 12.41% 7.56% 10.39% 7.67%
Lipper Category Avg. Mid-Cap Core Funds -9.25% -3.51% 12.53% 9.11% 11.26% -
Russell 2500™ Index -13.55% -11.62% 12.05% 9.76% 12.00% 8.38%

Fund Expense Ratio :

1.40%

Fund Expense Ratio :

1.40%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge -9.80% 2.44% 12.94% 9.01% 10.06% 8.24%
Lipper Category Avg. Mid-Cap Core Funds -4.50% 7.47% 13.46% 10.39% 10.95% -
Russell 2500™ Index -5.82% 0.34% 13.79% 11.57% 12.09% 9.13%

Fund Expense Ratio :

1.40%

Year Fund Returns Russell 2500™ Index
2021 26.88% 18.18%
2020 14.88% 19.99%
2019 22.53% 27.77%
2018 -12.04% -10.00%
2017 9.87% 16.81%
2016 16.16% 17.59%
2015 -3.14% -2.90%
2014 8.94% 7.07%
2013 35.86% 36.80%
2012 9.55% 17.88%
2011 -4.33% -
2010 24.42% -
2009 33.54% -
2008 -27.85% -
2007 10.72% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2022 -9.80% - - - -21.84%
2021 11.72% 3.59% 1.31% 8.21% 26.88%
2020 -25.38% 21.60% 4.10% 21.63% 14.88%
2019 11.84% 1.55% 1.25% 6.56% 22.53%
2018 -2.66% 2.84% 6.55% -17.53% -12.04%
2017 1.16% 1.93% 2.31% 4.15% 9.87%
2016 2.95% 2.47% 4.17% 5.70% 16.16%
2015 4.05% -0.25% -8.11% 1.56% -3.14%
2014 4.48% 2.73% -5.77% 7.72% 8.94%
2013 13.89% 2.03% 6.61% 9.66% 35.86%
2012 8.95% -7.17% 4.55% 3.60% 9.55%
2011 6.36% -0.48% -21.03% 14.45% -4.33%
2010 8.98% -9.54% 10.54% 14.17% 24.42%
2009 -6.52% 15.07% 19.16% 4.18% 33.54%
2008 -8.63% 0.58% -2.55% -19.43% -27.85%
2007 4.15% 9.30% 0.40% -3.13% 10.72%

NAV HISTORICAL PRICES

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 3/31/2022

  • The Fund employs a fundamental, bottom-up individual stock selection strategy that focuses on quality companies with compelling valuation over a long term horizon.
  • We initiated a position in shares of Organon & Co, a science-based global pharmaceutical company. The company was recently spun off from Merck & Co., Inc. We believe they are trading at an attractive valuation. The company is increasing the business mix towards biologics and women’s health which we believe will result in better growth and higher margins over time.
  • We also initiated a position in shares of Selective Insurance Group, Inc., a property and casualty insurance provider. We believe they are attractively valued and well-positioned as a small property and casualty insurance provider producing stable returns.
  • We sold the Fund’s position in Western Alliance Bancorp, a bank holding company, following the acquisition of AmeriHome. We saw a change in the business model that was inconsistent with our expectations.
  • We sold the Fund’s position in Evercore, Inc., an investment banking advisory company, in favor of what we consider to be more attractive investment opportunities consistent with our normalized free cash flow methodology.

PORTFOLIO DETAILS as of 05/31/2022

Total Net Assets
$1.47 B
Number of Holdings
68
Weighted Average Market Cap.
9.5 B
P/B Ratio
3.0x
P/E Ratio
16.9x

Contributors & Detractors as of  03/31/2022

Contributors

Holding Contribution
Devon Energy Corp 0.7%
Chesapeake Energy Corp 0.6%
Reliance Steel & Aluminum Co. 0.2%
American Financial Group, Inc. 0.1%
Euronet Worldwide Inc 0.1%

Detractors

Holding Contribution
Saia Inc -0.5%
Silicon Motion Technology Corp -0.5%
Stewart Information -0.5%
Axalta Coating Systems Ltd -0.4%
Criteo S.A. -0.4%

Attribution Analysis 

Value Opportunities Fund Benchmark Variance
Sector Avg. Weight Base Return Avg. Weight Base Return Stock Selection Group Weight Total

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 06/24/2022
$0
Dividend Frequency
Annually
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
11/20/2019 11/21/2019 11/21/2019 $0.01070 $16.28

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/21/2022 11/22/2022 11/22/2022

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/22/2021 11/23/2021 $2.5574 $0.3207 $2.8781 $20.54

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
11/21/2022 11/22/2022

Fees & Expenses

Fees & Expenses

EXPENSE RATIOas of 05/31/2022

1.40%

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
n/a
Portfolio Holdings 1Q
Publish Date:11/03/2015
n/a
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2500™ Index is a market cap weighted index that includes the smallest 2,500 companies covered in the Russell 3000 universe of United States-based listed equities.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field